Haemonetics Anticoagulant Citrate Dextrose Solution is a Extracorporeal Solution in the Human Prescription Drug category. It is labeled and distributed by Haemonetics Corporation. The primary component is Anhydrous Citric Acid; Trisodium Citrate Dihydrate; Dextrose Monohydrate.
| Product ID | 57826-426_6ad8c143-8921-7ce1-e053-2a91aa0a6d78 |
| NDC | 57826-426 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Haemonetics Anticoagulant Citrate Dextrose Solution |
| Generic Name | Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Dextrose Monohydrate |
| Dosage Form | Solution |
| Route of Administration | EXTRACORPOREAL |
| Marketing Start Date | 2013-01-10 |
| Marketing Category | ANDA / ANDA |
| Application Number | BA980728 |
| Labeler Name | Haemonetics Corporation |
| Substance Name | ANHYDROUS CITRIC ACID; TRISODIUM CITRATE DIHYDRATE; DEXTROSE MONOHYDRATE |
| Active Ingredient Strength | 73 mg/mL; mg/mL; mg/mL |
| Pharm Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |